US6048729A
(en)
|
1987-05-01 |
2000-04-11 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6001350A
(en)
*
|
1987-12-11 |
1999-12-14 |
Somatix Therapy Corp |
Genetic modification of endothelial cells
|
US6140111A
(en)
*
|
1987-12-11 |
2000-10-31 |
Whitehead Institute For Biomedical Research |
Retroviral gene therapy vectors and therapeutic methods based thereon
|
US6544771B1
(en)
|
1987-12-11 |
2003-04-08 |
Cell Genesys, Inc. |
Retroviral gene therapy vectors and therapeutic methods based thereon
|
DE69123981T3
(de)
*
|
1990-10-31 |
2006-06-14 |
Cell Genesys Inc |
Nützliche retrovirale vektoren für die gentherapie
|
NZ245015A
(en)
|
1991-11-05 |
1995-12-21 |
Transkaryotic Therapies Inc |
Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
|
US6054288A
(en)
*
|
1991-11-05 |
2000-04-25 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6692737B1
(en)
|
1991-11-05 |
2004-02-17 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6063630A
(en)
|
1991-11-05 |
2000-05-16 |
Transkaryotic Therapies, Inc. |
Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
|
FR2683725B1
(fr)
*
|
1991-11-15 |
1995-07-07 |
Pasteur Institut |
Composition cellulaire pour le traitement des organismes humains ou animaux.
|
US6348327B1
(en)
|
1991-12-06 |
2002-02-19 |
Genentech, Inc. |
Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells
|
AU3467193A
(en)
|
1991-12-17 |
1993-07-19 |
Regents Of The University Of California, The |
Gene therapy for cystic fibrosis transmembrane conductance regulator activity (CFTR)
|
US5858784A
(en)
*
|
1991-12-17 |
1999-01-12 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol- and liposome-based delivery
|
US5756353A
(en)
*
|
1991-12-17 |
1998-05-26 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol-and liposome-based delivery
|
US6627615B1
(en)
|
1991-12-17 |
2003-09-30 |
The Regents Of The University Of California |
Methods and compositions for in vivo gene therapy
|
US5336615A
(en)
*
|
1992-01-06 |
1994-08-09 |
Yale University |
Genetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activity
|
AU3429993A
(en)
*
|
1992-01-10 |
1993-08-03 |
Georgetown University |
A method of administering genetically engineered endothelial cells to sites of angiogenesis for effecting genetic therapy
|
US6806084B1
(en)
|
1992-06-04 |
2004-10-19 |
The Regents Of The University Of California |
Methods for compositions for in vivo gene delivery
|
IL105914A0
(en)
*
|
1992-06-04 |
1993-10-20 |
Univ California |
Methods and compositions for in vivo gene therapy
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
US6531124B1
(en)
|
1992-07-10 |
2003-03-11 |
Transkaryotic Therapies, Inc. |
In vivo production and delivery of insulinotropin for gene therapy
|
ATE212665T1
(de)
|
1992-11-18 |
2002-02-15 |
Arch Dev Corp |
Adenovirus gelenkter gen-transfer zum herz- und glatten vaskularen muskel
|
US5645829A
(en)
*
|
1993-06-18 |
1997-07-08 |
Beth Israel Hospital Association |
Mesothelial cell gene therapy
|
IL113052A0
(en)
|
1994-03-23 |
1995-06-29 |
Rhone Poulenc Rorer Sa |
Recombinant viruses, their preparation and their use in gene therapy
|
WO1995025547A1
(fr)
*
|
1994-03-24 |
1995-09-28 |
University Of Washington |
Dispositif et methodes d'implantation de cellules ayant subi une transduction
|
WO1996006933A1
(fr)
*
|
1994-08-26 |
1996-03-07 |
Sandoz Ltd. |
Therapie genique destinee a la transplantation et a des etats inflammatoires ou thrombotiques
|
US5704910A
(en)
|
1995-06-05 |
1998-01-06 |
Nephros Therapeutics, Inc. |
Implantable device and use therefor
|
CN1052915C
(zh)
*
|
1995-11-27 |
2000-05-31 |
中国医学科学院生物医学工程研究所 |
用于携载基因的蛋白质涂层医用载体及其制作方法
|
US6723531B2
(en)
|
1996-04-05 |
2004-04-20 |
The Salk Institute For Biological Studies |
Method for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
FR2758569B1
(fr)
*
|
1997-01-20 |
1999-04-02 |
Centre Nat Rech Scient |
Materiel biologique pour le traitement d'un mammifere par transfert de gene d'anticorps et composition pharmaceutique le concernant
|
US6300488B1
(en)
|
1997-07-10 |
2001-10-09 |
The Salk Institute For Biological Studies |
Modified lepidopteran receptors and hybrid multifunctional proteins for use in transcription and regulation of transgene expression
|
US6206914B1
(en)
*
|
1998-04-30 |
2001-03-27 |
Medtronic, Inc. |
Implantable system with drug-eluting cells for on-demand local drug delivery
|
US6333318B1
(en)
|
1998-05-14 |
2001-12-25 |
The Salk Institute For Biological Studies |
Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
JP2002537761A
(ja)
|
1998-11-24 |
2002-11-12 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
トランスジェニック循環内皮細胞
|
US7504253B2
(en)
|
1999-06-11 |
2009-03-17 |
The Burnham Institute For Medical Research |
Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof
|
JP2003509463A
(ja)
*
|
1999-09-23 |
2003-03-11 |
アン−ゴー−ジェン インコーポレーテッド |
肺系のための細胞ベースの遺伝子治療
|
US7057015B1
(en)
|
1999-10-20 |
2006-06-06 |
The Salk Institute For Biological Studies |
Hormone receptor functional dimers and methods of their use
|
AU2001231009A1
(en)
|
2000-01-21 |
2001-07-31 |
Beth Israel Deaconess Medical Center |
Use of pro-apoptotic factors in treatment of atherosclerosis
|
US6706688B2
(en)
|
2001-03-09 |
2004-03-16 |
Paula Sundstrom |
Methods for regulating bud-hypha transitions and cAMP levels by the adenylate cyclase-associated protein gene, CAP1
|
US7270975B2
(en)
|
2001-03-09 |
2007-09-18 |
Trustees Of Dartmouth College |
Methods for regulating bud-hypha transitions and cAMP levels in Candida albicans
|
WO2002094871A1
(fr)
|
2001-05-24 |
2002-11-28 |
Human Dna Technology Inc |
Nouvel analogue du facteur de croissance des keratinocytes-2 du follicule pileux
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
CA2524619A1
(fr)
|
2005-11-22 |
2007-05-22 |
Ottawa Health Research Institute |
Nouvelles cellules souches, sequences nucleotides et proteines provenant de celles-ci
|
RU2471487C2
(ru)
|
2007-02-06 |
2013-01-10 |
Тай Джун ЙОО |
Лечение и предупреждение нейродегенеративных заболеваний с использованием генной терапии
|
US9029144B2
(en)
|
2008-06-18 |
2015-05-12 |
Innovative Bio Therapies, Inc. |
Methods for enhanced propagation of cells
|
EP2755681B1
(fr)
|
2011-09-15 |
2018-06-27 |
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center |
IMMUNOTHÉRAPIE ET DIAGNOSTIC DE LA MUCORMYCOSE AU MOYEN DE CotH
|
WO2014197535A1
(fr)
|
2013-06-04 |
2014-12-11 |
Virginia Commonwealth University |
Cytokines thérapeutiques recombinantes contre le cancer
|
WO2014209553A1
(fr)
|
2013-06-04 |
2014-12-31 |
Virginia Commonwealth University |
Utilisation d'un promoteur de ccn1 tronqué pour le diagnostic, la thérapeutique et la théragnostique de cancer
|
EP3003393A4
(fr)
|
2013-06-04 |
2017-01-11 |
The Johns Hopkins University |
Produits de recombinaison d'acides nucléiques tripartites utilisables dans le cadre de la théranostique du cancer
|
WO2014197599A1
(fr)
|
2013-06-04 |
2014-12-11 |
The Johns Hopkins University |
Expression en surface de l'avidine/streptavidine, médiée par peg-prom
|
WO2014197586A1
(fr)
|
2013-06-04 |
2014-12-11 |
Virginia Commonwealth University |
Promoteur du gène de la synténine (mda-9) utilisé pour la prise d'image et le traitement de cellules cancéreuses métastatiques
|
EP3299460A1
(fr)
|
2016-09-26 |
2018-03-28 |
Johann Wolfgang Goethe-Universität Frankfurt am Main |
Nouveaux composes et procedes destines a moduler l'expression de l'ubiquitination
|
GB201710973D0
(en)
|
2017-07-07 |
2017-08-23 |
Avacta Life Sciences Ltd |
Scaffold proteins
|
EP4013788A1
(fr)
|
2019-08-12 |
2022-06-22 |
Purinomia Biotech, Inc. |
Méthodes et compositions pour favoriser et potentialiser des réponses immunitaires à médiation par des lymphocytes t par ciblage adcc de cellules exprimant cd39
|
TW202128775A
(zh)
|
2019-10-16 |
2021-08-01 |
英商阿法克塔生命科學有限公司 |
PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分
|
GB202101299D0
(en)
|
2020-06-09 |
2021-03-17 |
Avacta Life Sciences Ltd |
Diagnostic polypetides and methods
|
WO2022234003A1
(fr)
|
2021-05-07 |
2022-11-10 |
Avacta Life Sciences Limited |
Polypeptides se liant à cd33 avec protéine stefin a
|
TW202334196A
(zh)
|
2021-10-07 |
2023-09-01 |
英商阿法克塔生命科學有限公司 |
Pd-l1結合多肽
|
TW202332694A
(zh)
|
2021-10-07 |
2023-08-16 |
英商阿凡克塔生命科學公司 |
血清半衰期延長之pd-l1結合多肽
|